Journal Of Clinical Oncology (jco) Podcast
Deciphering the Heterogeneity Within EGFR-mutant Lung Cancer
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:06:54
- More information
Informações:
Synopsis
A meta-analysis of 7 randomized trials comparing EGFR kinase inhibitors to chemotherapy for advanced EGFR-mutant lung cancer has shown that some populations gain greater benefit from targeted therapy – namely never-smokers, woman, and tumor harboring exon 19 deletions.
